Article
Bioglam Pharma Inc. launched ADOXA Tablets, the first and only doxycycline monohydrate tablets for the treatment of severe acne.
Monica K. Li, MD: Global Innovations, Integration with Other Modalities, and Future Trends in Microneedling
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
National Eczema Association Expands Visual Guide to Address Skin Tone Disparities
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Celebrating Second Annual National Dermatologist Day with Launch of EltaMD’s ‘Derm Difference’ Campaign
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis